PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,663 stories, page 49 of 812

Advanced search
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Posted Integrated Report 2026

Sumitomo PharmaOriginal source
🇺🇸Industryelementbiosciences.comTier 1 · Company source

Element Biosciences Launches AVITI Dx™, Bringing CE-Marked IVD Sequencing to Ten EU Countries

Element BiosciencesOriginal source
🇪🇸Researchclinicbarcelona.orgTier 2 · Direct publisher

El Clínic receives a #PorElClima Healthcare Award for its strategy to reduce the environmental impact of dialysis

Hospital Clínic de BarcelonaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical H1 Core Earnings, Revenue Rise; 2026 Guidance Lifted

Yahoo FinanceOriginal source
🌍Industryamarin.co.thTier 3 · Secondary coverage

AMARIN คว้า CG Rating ระดับ 5 ดาว ต่อเนื่องปีที่ 5

Amarin CorporationOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100

DagangNewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Raises Annual Guidance

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moscow and Managua deepen pharmaceutical partnership at congress in Nicaragua

Новости GxPOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. Restricts Trade With Chinese Genomics Company

The New York TimesOriginal source
🇸🇪Industrysobi.comTier 1 · Company source

Late-breaking Phase 3 REDUCE-2 data show clinically meaningful and durable serum urate lowering with pozdeutinurad

Detailed efficacy and safety results from the pivotal phase 3 study demonstrate statistically signif...

Swedish Orphan BiovitrumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Top 10 Agitated Nutsche Filter Dryer Manufacturers in 2026: Advancing Pharmaceutical Production

EIN NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical (TSE:4519) Stock Price Trails Strong Q3 Earnings

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

The HillOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

AP NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA-Approved Antibody-Drug Conjugates Reshape Blood Cancer Treatment

Bioengineer.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PM says to foster 200 'frontier' bio, pharmaceutical firms by 2030

The Korea HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical spending linked to lower treatable deaths in Spain

Bioengineer.orgOriginal source
🇯🇵Researchjsmo.or.jpTier 2 · Direct publisher

医薬品・医療機器等安全性情報 No.433（厚生労働省）

Japanese Society of Medical OncologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Inside Biotech: Mesoblast surges 24% as Ryoncil sales climb and cash spend falls sharply

Yahoo Finance AustraliaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea’s First Homegrown Obesity Drug Begins Prescriptions, Challenging Mounjaro on Price

BusinesskoreaOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Early Alert: Medline Removes or Corrects All Medline Brand Beds and Accessories

Medline removes or corrects all brand beds & accessories due to fire, electrical overheating, entrap...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Industry in Crisis: A Threat to Public Health

Pressenza - International Press AgencyOriginal source
🇺🇸Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Concomitant Aveir AR and Micra AV2 Hybrid Leadless Implantation During Infected Pacemaker Extraction

Pacing and Clinical ElectrophysiologyOriginal source
🇺🇸Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Insertable Cardiac Monitoring in Pediatric Patients: A Real‐World Single‐Center Experience With a New‐Generation Device

Pacing and Clinical ElectrophysiologyOriginal source
🇺🇸Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Feasibility of Left Bundle Branch Pacing and Management of Jailed Leads After Transcatheter Tricuspid Valve Implantation

Pacing and Clinical ElectrophysiologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr. plans to make 6 unapproved peptides available for temporary sale

The Washington PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SciVision Biotech's Drug-Containing Hyaluronic Acid Filler Wins China Class III Medical Device Certificate; Shares Gap Up and Lock at Limit-High NT$43.25

BigGo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical : Revenue fell 9.6%, but core operating profit rose 5.1%

TradingViewOriginal source
🇯🇵Regulatorypmda.go.jpTier 1 · Regulatory source

[SHINSA]English Translation of Review Report: Zurzuvae

PMDA JapanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Clarifies Regulatory Standards for Prescription Drug Apps, Including Device-Linked and Standalone Software

헬스조선Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Protina Secures Osteoarthritis Drug Patents in 8 Countries; Due Diligence Underway with 2 Japanese Pharma Companies for Licensing Deal

BigGo FinanceOriginal source
🇺🇸Industrythefdalawblog.comTier 3 · Secondary coverage

The Flexibility Papers, No. 1: First Principles for a Rare Disease Framework

Hyman, Phelps & McNamara (FDA Law)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

The MercuryOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HHS Plan for Peptide Drug Access Faces FDA Opposition Amid Safety Concerns

SSBCrackOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr. to ease access to unapproved peptides, draft policy states

CBS NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr. eases access to unproven peptides despite opposition from FDA scientists

The Washington PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Idorsia starts pivotal Phase 3 trial for Fabry disease drug lucerastat and signs Asia-Pacific deal with Nxera

DealroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea's First Domestic Obesity Drug 'Epe' Available for Prescription Starting Today... Three-Way Race with Mounjaro and Wegovy

news.sbs.co.krOriginal source
🇺🇰Regulatoryabpi.org.ukTier 1 · Regulatory source

New research shows varied access to new medicines across Scotland

ABPI UKOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Gilead Sciences filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Eli Lilly filed Form 10-Q

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Eli Lilly filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Merck filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Bristol Myers Squibb filed Form 10-Q

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Bristol Myers Squibb filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Reducing Bureaucracy and Burden for Block Grants

ACF proposes to amend its block grant regulations to modernize requirements, reduce administrative b...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Urine (UrMG)

The Department of Health and Human Services ("HHS" or "Department") is proposing to revise the Manda...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Oral Fluid (OFMG)

The Department of Health and Human Services ("HHS" or "Department") is proposing to revise the Manda...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Office of the Director, National Institutes of Health; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Reducing Bureaucracy and Burden for Child Support Enforcement Programs

This final rule amends the Child Support regulations that were unnecessary or obsolete in the follow...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Fogarty International Center; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute on Aging; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Submission for OMB Review; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Request. 60-Day Public Comment Request

In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secreta...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.

Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of bas...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Privacy Act of 1974; Matching Program

In accordance with subsection (e)(12) of the Privacy Act of 1974, as amended, the Department of Heal...

Federal RegisterOriginal source